RU2667634C2 - Способы диагностики хронического заболевания клапанов - Google Patents

Способы диагностики хронического заболевания клапанов Download PDF

Info

Publication number
RU2667634C2
RU2667634C2 RU2014153109A RU2014153109A RU2667634C2 RU 2667634 C2 RU2667634 C2 RU 2667634C2 RU 2014153109 A RU2014153109 A RU 2014153109A RU 2014153109 A RU2014153109 A RU 2014153109A RU 2667634 C2 RU2667634 C2 RU 2667634C2
Authority
RU
Russia
Prior art keywords
sample
animal
valve disease
amount
metabolites
Prior art date
Application number
RU2014153109A
Other languages
English (en)
Russian (ru)
Other versions
RU2014153109A (ru
Inventor
Цинхун ЛИ
Дороти П. ЛАФЛАМ
Стивен С. ХАННА
Original Assignee
Нестек Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек Са filed Critical Нестек Са
Publication of RU2014153109A publication Critical patent/RU2014153109A/ru
Application granted granted Critical
Publication of RU2667634C2 publication Critical patent/RU2667634C2/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y10T436/163333—Organic [e.g., chemical warfare agents, insecticides, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Endocrinology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
RU2014153109A 2012-06-05 2013-06-04 Способы диагностики хронического заболевания клапанов RU2667634C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261655704P 2012-06-05 2012-06-05
US61/655,704 2012-06-05
PCT/US2013/044008 WO2013184628A1 (en) 2012-06-05 2013-06-04 Methods for diagnosing chronic valvular disease

Publications (2)

Publication Number Publication Date
RU2014153109A RU2014153109A (ru) 2016-08-10
RU2667634C2 true RU2667634C2 (ru) 2018-09-21

Family

ID=48626663

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014153109A RU2667634C2 (ru) 2012-06-05 2013-06-04 Способы диагностики хронического заболевания клапанов

Country Status (12)

Country Link
US (1) US20150153353A1 (https=)
EP (1) EP2856170B1 (https=)
JP (1) JP6174689B2 (https=)
CN (1) CN104364658B (https=)
AU (1) AU2013271879B2 (https=)
BR (1) BR112014030243B1 (https=)
CA (1) CA2875331C (https=)
ES (1) ES2687979T3 (https=)
IN (1) IN2014DN10127A (https=)
MX (1) MX358561B (https=)
RU (1) RU2667634C2 (https=)
WO (1) WO2013184628A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2826160C2 (ru) * 2018-12-27 2024-09-05 Сосьете Де Продюи Нестле Са Композиции и способы диагностики и лечения дегенеративного заболевания митрального клапана у животного из семейства собачьих

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10184932B2 (en) * 2015-12-07 2019-01-22 Zora Biosciences Oy Use of ceramides and LPLs in diagnosing CVD

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2435165C2 (ru) * 2005-01-25 2011-11-27 СиАйЭс БАЙОТЕК, ИНК. Биомаркеры ишемии и их применение для прогнозирования неблагоприятных неврологических последствий хирургической операции

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010000414A (es) * 2007-07-17 2010-04-01 Metabolon Inc Biomarcadores para prediabetes, enfermedades cardiovasculares y otros trastornos relacionados con sindrome metabolico, y metodos de uso de los mismos.
JP5654352B2 (ja) * 2007-11-09 2015-01-14 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム ｍｉＲ−１５ファミリーのマイクロＲＮＡによる心筋細胞生存及び心臓修復の調節
EP2283358B1 (en) * 2008-04-29 2015-04-22 Immunexcite, Inc. Immunomodulating compositions and methods of use thereof
DK2271933T3 (da) * 2008-05-07 2013-04-02 Univ Strathclyde System og fremgangsmåde til cellekarakterisering
SG172855A1 (en) * 2009-01-29 2011-08-29 Abbott Lab Il-1 binding proteins
EP2596134B1 (en) * 2010-07-23 2020-04-08 President and Fellows of Harvard College Methods of detecting diseases or conditions using phagocytic cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2435165C2 (ru) * 2005-01-25 2011-11-27 СиАйЭс БАЙОТЕК, ИНК. Биомаркеры ишемии и их применение для прогнозирования неблагоприятных неврологических последствий хирургической операции

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ATKINS C. et al, Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart Disease, J Vet Intern Med., 2009, 23, pp.1142-1150, найдено 30.05.2017 в Интернете [on-line] на сайте http://www.ivis.org/proceedings/acvim/consensus/caninevalvularheartdz.pdf. *
КЛЮЕВ Н. А. и др. Современные методы масс-спектрометрического анализа органических соединений. Ж. Рос. хим. об-ва им. Д.И. Менделеева, 2002, XLVI, 4, стр. 57-63, найдено 30.05.2017 в Интернете [on-line] на сайте http://www.chem.msu.su/rus/jvho/2002-4/57.pdf. *
СКВОРЦОВ В.В. и др. Актуальные вопросы диагностики и лечения язвенной болезни желудка и 12-перстной кишки. Больница, 2010, 4, стр. 13-17, найдено 30.05.2017 в Интернете [on-line] на сайте http://www.gastroscan.ru/literature/authors/4232. *
ШЕСТОПАЛОВА И.М. и др. Принципы диагностики и лечения карциноидной болезни сердца при нейроэндокринных опухолях. Вестник РОНЦ им. Н. Н. Блохина РАМН, 2011, 3, 22, стр. 21-26, найдено 30.05.2017 в Интернете [on-line] на сайте http://cyberleninka.ru/article/n/printsipy-diagnostiki-i-lecheniya-kartsinoidnoy-bolezni-serdtsa-pri-neyroendokrinnyh-opuholyah. *
ШЕСТОПАЛОВА И.М. и др. Принципы диагностики и лечения карциноидной болезни сердца при нейроэндокринных опухолях. Вестник РОНЦ им. Н. Н. Блохина РАМН, 2011, 3, 22, стр. 21-26, найдено 30.05.2017 в Интернете [on-line] на сайте http://cyberleninka.ru/article/n/printsipy-diagnostiki-i-lecheniya-kartsinoidnoy-bolezni-serdtsa-pri-neyroendokrinnyh-opuholyah. КЛЮЕВ Н. А. и др. Современные методы масс-спектрометрического анализа органических соединений. Ж. Рос. хим. об-ва им. Д.И. Менделеева, 2002, XLVI, 4, стр. 57-63, найдено 30.05.2017 в Интернете [on-line] на сайте http://www.chem.msu.su/rus/jvho/2002-4/57.pdf. СКВОРЦОВ В.В. и др. Актуальные вопросы диагностики и лечения язвенной болезни желудка и 12-перстной кишки. Больница, 2010, 4, стр. 13-17, найдено 30.05.2017 в Интернете [on-line] на сайте http://www.gastroscan.ru/literature/authors/4232. ATKINS C. et al, Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart Disease, J Vet Intern Med., 2009, 23, pp.1142-1150, найд *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2826160C2 (ru) * 2018-12-27 2024-09-05 Сосьете Де Продюи Нестле Са Композиции и способы диагностики и лечения дегенеративного заболевания митрального клапана у животного из семейства собачьих

Also Published As

Publication number Publication date
WO2013184628A1 (en) 2013-12-12
RU2014153109A (ru) 2016-08-10
EP2856170B1 (en) 2018-07-25
CN104364658B (zh) 2017-06-30
CA2875331A1 (en) 2013-12-12
MX358561B (es) 2018-08-24
MX2014014791A (es) 2015-02-24
BR112014030243A2 (pt) 2017-06-27
AU2013271879A1 (en) 2014-12-18
US20150153353A1 (en) 2015-06-04
BR112014030243B1 (pt) 2022-07-05
JP6174689B2 (ja) 2017-08-02
CA2875331C (en) 2022-11-29
JP2015524066A (ja) 2015-08-20
IN2014DN10127A (https=) 2015-08-21
CN104364658A (zh) 2015-02-18
EP2856170A1 (en) 2015-04-08
ES2687979T3 (es) 2018-10-30
AU2013271879B2 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
Muthubharathi et al. Metabolomics: small molecules that matter more
Schlotterbeck et al. Metabolic profiling technologies for biomarker discovery in biomedicine and drug development
Khamis et al. Mass spectrometric based approaches in urine metabolomics and biomarker discovery
González‐Domínguez et al. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis–mass spectrometry
Roede et al. Serum metabolomics of slow vs. rapid motor progression Parkinson’s disease: a pilot study
JP6763770B2 (ja) 自閉症スペクトラム障害のバイオマーカー
JP6021187B2 (ja) 自閉症の代謝バイオマーカー
US20050101023A1 (en) Methods for diagnosing urinary tract and prostatic disorders
Bu et al. Metabolomics: a revolution for novel cancer marker identification
AU2014265669A1 (en) Biomarkers related to kidney function and methods using the same
US20140297195A1 (en) Method and Use of Metabolites for the Diagnosis of Inflammatory Brain Injury in Preterm Born Infants
WO2017082103A1 (ja) うつ病診断用バイオマーカー及びその使用
Pont et al. Metabolic profiling for the identification of Huntington biomarkers by on‐line solid‐phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools
Vogl et al. Evaluation of dilution and normalization strategies to correct for urinary output in HPLC-HRTOFMS metabolomics
LeWitt et al. Diagnostic metabolomic profiling of Parkinson's disease biospecimens
Bereman et al. Metabolite profiling reveals predictive biomarkers and the absence of β-methyl amino-l-alanine in plasma from individuals diagnosed with amyotrophic lateral sclerosis
Mill et al. Recent advances in understanding of Alzheimer’s disease progression through mass spectrometry-based metabolomics
Patel et al. Improved detection and precise relative quantification of the urinary cancer metabolite biomarkers–Creatine riboside, creatinine riboside, creatine and creatinine by UPLC-ESI-MS/MS: Application to the NCI-Maryland cohort population controls and lung cancer cases
Anderson et al. In-depth chemical analysis of the brain extracellular space using in vivo microdialysis with liquid chromatography-tandem mass spectrometry
Vallianatou et al. Rapid metabolic profiling of 1 μL crude cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry imaging can differentiate De Novo Parkinson’s disease
CN112305121B (zh) 代谢标志物在动脉粥样硬化性脑梗死中的应用
US11092591B2 (en) Host and intestinal microbiota derived metabolomic blood plasma signature for prior radiation injury
RU2667634C2 (ru) Способы диагностики хронического заболевания клапанов
CN112630344B (zh) 代谢标志物在脑梗死中的用途
EP3149473B1 (en) Metabolic biomarkers for memory loss

Legal Events

Date Code Title Description
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20190916